| 2019-08 | HDAC Inhibition by Valproic Acid Induces Neuroprotection and Improvement of PD-like Behaviors in LRRK2 R1441G Transgenic Mice | 서혜명 |
| 2015-10 | High DJ-1 level in urine exosome of Koreans with Parkinson's disease | 서혜명 |
| 2020-01 | Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models | 서혜명 |
| 2013-03 | Identification of cancer-specific biomarkers by using microarray gene expression profiling | 서혜명 |
| 2018-09 | Increase in anti-apoptotic molecules, nucleolin, and heat shock protein 70, against upregulated LRRK2 kinase activity | 서혜명 |
| 2014-11 | Increased DJ-1 in Urine Exosome of Korean Males with Parkinson's Disease | 서혜명 |
| 2015-10 | Increased TRPC5 glutathionylation contributes to striatal neuron loss in Huntington's disease | 서혜명 |
| 2020-03 | Iroquois homeobox protein 2 identified as a potential biomarker for Parkinson's disease | 서혜명 |
| 2014-11 | JMJD2A attenuation affects cell cycle and tumourigenic inflammatory gene regulation in lipopolysaccharide stimulated neuroectodermal stem cells | 서혜명 |
| 2015-09 | Leucine-Rich Repeat Kinase 2 (LRRK2) phosphorylates p53 and induces p21(WAF1/CIP1) expression | 서혜명 |
| 2017-01 | Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase 3 and histone deacetylation | 서혜명 |
| 2017-01 | Leucine-rich repeat kinase 2 exacerbates neuronal cytotoxicity through phosphorylation of histone deacetylase3 and histone deacetylation. | 서혜명 |
| 2015-09 | LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase | 서혜명 |
| 2013-08 | LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25 | 서혜명 |
| 2021-09 | Matrix Metalloproteinase-8 Inhibitor Ameliorates Inflammatory Responses and Behavioral Deficits in LRRK2 G2019S Parkinson's Disease Model Mice | 서혜명 |
| 2021-05 | Matrix Metalloproteinase-8 Inhibitor Ameliorates Inflammatory Responses and Behavioral Deficits in LRRK2G2019S Parkinson's Disease Model Mice | 서혜명 |
| 2014-07 | miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling | 서혜명 |
| 2016-01 | MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons | 서혜명 |
| 2021-03 | Modulation of SETDB1 activity by APQ ameliorates heterochromatin condensation, motor function, and neuropathology in a Huntington's disease mouse model | 서혜명 |
| 2023-09 | Multicomponent metal-organic framework nanocomposites for tumor-responsive synergistic therapy | 서혜명 |
| 2016-05 | Neuroanatomical Visualization of the Impaired Striatal Connectivity in Huntington's Disease Mouse Model | 서혜명 |
| 2018-05 | Oxidized DJ-1 Levels in Urine Samples as a Putative Biomarker for Parkinson's Disease. | 서혜명 |
| 2018-05 | Oxidized DJ-1 Levels in Urine Samples as a Putative Biomarker for Parkinson's Disease | 서혜명 |
| 2020-05 | Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease | 서혜명 |
| 2012-07 | Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson's disease | 서혜명 |
| 2014-08 | Prediction of miRNA-mRNA associations in Alzheimer's disease mice using network topology | 서혜명 |
| 2007-02 | Proteasome Activator Enhances Survival of Huntington's Disease Neuronal Model Cells | 서혜명 |
| 2015-06 | Reduction of Nfia gene expression and subsequent target genes by binge alcohol in the fetal brain | 서혜명 |
| 2007-11 | Regulation of functional phenotypes of cord blood-derived eosinophils gamma-secretase inhibitor | 서혜명 |
| 2007-11 | Regulation of Functional Phenotypes of Cord-blood-derived Eosinophils by gamma-secretase inhibitor | 서혜명 |
